---
figid: PMC2685917__halms340599f9
figtitle: Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax-
  and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small
  cell lung cancer cells
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC2685917
filename: halms340599f9.jpg
figlink: /pmc/articles/PMC2685917/figure/F9/
number: F9
caption: 'A: Signaling pathways activated by IGF1 or AR growth factors used as single
  agent. IGF1 activates the IGF1 receptor and the PI3K/Akt pathway. AR activates the
  EGF receptor which is linked to the MAPK/ERK and the PI3K/Akt pathways. Both IGF1
  and EGF receptors converge to the inactivation of the pro-apoptotic protein Bad.
  B: Survival pathway activated by the cooperation of IGF1 and AR growth factors.
  AR and IGF1, present in the H358 CM, activate both IGF1 and EGF receptors (box)
  (). This cooperation induces a PKC-dependent survival pathway, independent of MAPK/ERK
  and PI3K/Akt pathways. This anti-apoptotic pathway leads to Bad phosphorylation
  on Ser112 and inhibition of conformational change of the pro-apoptotic protein Bax.
  Inhibitors used are mentioned in blue.'
papertitle: Cooperation of amphiregulin and insulin-like growth factor-1 inhibits
  Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small
  cell lung cancer cells.
reftext: Amandine Hurbin, et al. J Biol Chem. ;280(20):19757-19767.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.964723
figid_alias: PMC2685917__F9
figtype: Figure
redirect_from: /figures/PMC2685917__F9
ndex: 38574db7-ded4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2685917__halms340599f9.html
  '@type': Dataset
  description: 'A: Signaling pathways activated by IGF1 or AR growth factors used
    as single agent. IGF1 activates the IGF1 receptor and the PI3K/Akt pathway. AR
    activates the EGF receptor which is linked to the MAPK/ERK and the PI3K/Akt pathways.
    Both IGF1 and EGF receptors converge to the inactivation of the pro-apoptotic
    protein Bad. B: Survival pathway activated by the cooperation of IGF1 and AR growth
    factors. AR and IGF1, present in the H358 CM, activate both IGF1 and EGF receptors
    (box) (). This cooperation induces a PKC-dependent survival pathway, independent
    of MAPK/ERK and PI3K/Akt pathways. This anti-apoptotic pathway leads to Bad phosphorylation
    on Ser112 and inhibition of conformational change of the pro-apoptotic protein
    Bax. Inhibitors used are mentioned in blue.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - cm
  - ar
  - Egfr
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - rl
  - p38a
  - pk
  - pl
  - pi
  - Akt
  - srn
  - cass
  - 14-3-3zeta
  - 14-3-3epsilon
  - IGF1
  - AR
  - IGF1R
  - EGFR
  - PRKCG
  - PTHLH
  - PTH1R
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPK3
  - MAPK1
  - PLK1
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - AKT1
  - AKT2
  - AKT3
  - BAD
  - BAX
  - BCL2L1
  - Calphostin C
  - Rottlerin
  - LY294002
  - PD98059
  - U0126
  - Ser
  - Thr
  - Staurosporine
  - Cancer
---
